HUMA
Humacyte Inc
0.5573$
-2.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -92.8% | -41.8% | +150.2% | -38.0% | +6.0% | -18.0% | – | |
| – | +156.9% | -47.0% | +1.8% | -0.6% | +99.4% | -45.2% | +4.7% | +2.5% | +411.5% | -81.3% | -39.6% | – | |
| – | – | – | – | – | – | -140.5% | – | – | – | – | – | – | |
| – | +8.8% | +5.4% | +11.7% | -3.5% | -9.9% | -25.4% | +42.7% | -21.5% | -15.4% | +33.3% | -6.8% | – | |
| – | -1.1% | -11.5% | +8.1% | +27.2% | +1.7% | +9.5% | -4.0% | -2.5% | +202.7% | -65.6% | +1.2% | – | |
| – | -2.2% | +8.7% | +11.7% | +2.7% | +11.5% | -31.5% | +28.7% | -17.7% | -11.2% | +34.1% | -4.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +18.0% | +5.2% | +38.5% | -3.1% | +2.9% | +19.6% | -15.2% | +2.6% | +18.4% | -26.6% | +2.2% | – | |
| – | – | – | – | – | – | – | -196.2% | – | – | – | – | – | |
| – | -2,017.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -196.2% | – | – | – | – | – | |
| – | – | – | – | – | – | – | -175.6% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.